KDL(SH:603987) Sou Hu Cai Jing·2025-08-12 10:52Group 1 - The core viewpoint of the article highlights that Kangdelai's stock price closed at 9.25 yuan, with a PE ratio of 18.75, marking a new low in 387 days, and a total market capitalization of 4.04 billion yuan [1] - The average PE ratio for the medical device industry is 57.51, with a median of 41.25, placing Kangdelai at the 39th position within the industry [1] - As of the first quarter of 2025, three institutions hold shares in Kangdelai, with a total of 163,900 shares valued at 0.01 million yuan [1] Group 2 - Kangdelai's main business includes the research, production, sales, and service of medical devices such as puncture needles and infusion devices [1] - The company has established a Shanghai-level enterprise technology center for R&D, and its subsidiary in Zhejiang has set up a provincial research institute for puncture medical devices [1] - The latest financial results for the first quarter of 2025 show that Kangdelai achieved a revenue of 548 million yuan, a year-on-year decrease of 3.82%, and a net profit of 60.70 million yuan, with a gross profit margin of 32.02% [1]